Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Immune Oncology Research Institute
University of Oklahoma
Canadian Cancer Trials Group
Merck Sharp & Dohme LLC
OHSU Knight Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
GlaxoSmithKline
Ohio State University Comprehensive Cancer Center
University of Oklahoma
Hallym University Medical Center